Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,559,903 | 8,078,928 | 5,532,779 | 10,133,190 | 6,109,089 |
| Marketable Securities | 405,426 | 295,320 | 373,330 | 630,377 | 1,701,168 |
| Receivables | 9,905,356 | 9,787,933 | 10,878,250 | 9,301,787 | 11,394,500 |
| Inventories | 8,571,864 | 7,698,864 | 8,319,192 | 7,936,796 | 7,624,512 |
| Other current assets | 102,051 | 136,105 | 578,729 | 511,250 | 1,382,191 |
| TOTAL | $25,544,600 | $25,997,150 | $25,682,280 | $28,513,400 | $28,211,460 |
| Non-Current Assets | |||||
| PPE Net | 13,572,120 | 13,065,980 | 13,314,580 | 13,017,040 | 13,356,990 |
| Investments And Advances | 5,186,419 | 4,402,836 | 3,844,397 | 3,187,872 | 3,019,317 |
| Intangibles | 54,966,940 | 51,900,570 | 53,676,870 | 52,441,680 | 54,311,840 |
| Other Non-Current Assets | 8,400,861 | 7,906,864 | 8,023,383 | 7,869,788 | 9,193,733 |
| TOTAL | $82,126,340 | $77,276,250 | $78,859,230 | $76,516,380 | $79,881,880 |
| Total Assets | $107,670,900 | $103,273,400 | $104,541,500 | $105,029,800 | $108,093,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,374,188 | 4,782,900 | 6,347,905 | 7,400,728 | 9,306,465 |
| Accounts payable and accrued liabilities | 20,147,190 | 20,338,560 | 19,560,440 | 19,171,900 | 19,612,110 |
| Accrued Expenses | 910,140 | 699,780 | 552,890 | 850,017 | 1,044,015 |
| Other current liabilities | 2,527,707 | 2,616,792 | 2,189,601 | 2,264,643 | 2,491,545 |
| TOTAL | $27,959,220 | $28,438,030 | $28,650,830 | $29,687,290 | $32,454,130 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,781,810 | 30,077,700 | 30,142,860 | 31,923,390 | 31,693,220 |
| Other Non-Current Liabilities | 13,781,733 | 13,203,272 | 13,804,175 | 13,288,801 | 13,055,953 |
| TOTAL | $50,738,930 | $48,117,900 | $49,247,290 | $50,354,480 | $49,894,950 |
| Total Liabilities | $78,698,150 | $76,555,930 | $77,898,130 | $80,041,770 | $82,349,090 |
| Shareholders' Equity | |||||
| Common Shares | 1,856,134 | 1,728,264 | 1,738,763 | 1,670,251 | 1,724,226 |
| Retained earnings | 9,239,300 | 8,673,420 | 9,113,649 | 8,217,240 | 8,138,193 |
| Other shareholders' equity | 13,332,172 | 12,102,982 | 11,553,864 | 11,032,839 | 11,686,566 |
| TOTAL | $28,972,790 | $26,717,470 | $26,643,380 | $24,988,000 | $25,744,260 |
| Total Liabilities And Equity | $107,670,940 | $103,273,400 | $104,541,510 | $105,029,770 | $108,093,350 |